Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk
出版年份 2021 全文链接
标题
Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk
作者
关键词
Insulin resistance, Metabolic syndrome, Non-alcoholic fatty liver disease, Vascular risk, Treatment, Diabetes mellitus
出版物
METABOLISM-CLINICAL AND EXPERIMENTAL
Volume 119, Issue -, Pages 154770
出版商
Elsevier BV
发表日期
2021-04-15
DOI
10.1016/j.metabol.2021.154770
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Nonalcoholic Fatty Pancreas Disease: Role in Metabolic Syndrome, “Prediabetes,” Diabetes and Atherosclerosis
- (2021) T. D. Filippatos et al. DIGESTIVE DISEASES AND SCIENCES
- Role of the gut microbiota in type 2 diabetes and related diseases
- (2021) Ge Yang et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Gut microbiota and their metabolites in cardiovascular disease
- (2021) Valérie LBI. Jansen et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Role of Gut Microbiota, Probiotics and Prebiotics in the Cardiovascular Diseases
- (2021) Anna Oniszczuk et al. MOLECULES
- Liver stiffness quantification in biopsy-proven nonalcoholic fatty liver disease patients using shear wave elastography in comparison with transient elastography
- (2021) Adele Taibbi et al. Ultrasonography
- Efficacy and safety of anti-hyperglycaemic drugs in patients with non-alcoholic fatty liver disease with or without diabetes: An updated systematic review of randomized controlled trials
- (2020) A. Mantovani et al. DIABETES & METABOLISM
- The Emerging Epidemic of Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: True, True, and Related?
- (2020) Jordan E. Morningstar et al. DIGESTIVE DISEASES AND SCIENCES
- Established and emerging factors affecting the progression of nonalcoholic fatty liver disease
- (2020) Stergios Kechagias et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitis
- (2020) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Association between non-alcoholic fatty liver disease and coronary calcification depending on sex and obesity
- (2020) Seok-hyung Kim et al. Scientific Reports
- FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study
- (2020) Philip N Newsome et al. Lancet Gastroenterology & Hepatology
- Non‐alcoholic fatty liver disease is associated with cardiovascular disease in subjects with different glucose tolerance
- (2020) Teresa Vanessa Fiorentino et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Weight-centric pharmacological management of type 2 diabetes mellitus – An essential component of cardiovascular disease prevention
- (2020) Emir Muzurović et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Association of Serum Homocysteine Levels with Histological Severity of NAFLD
- (2020) Yilun Xu et al. Journal of Gastrointestinal and Liver Diseases
- Advances in non-invasive biomarkers for the diagnosis and monitoring of non-alcoholic fatty liver disease
- (2020) Michelle T. Long et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis
- (2020) Qing Ye et al. Lancet Gastroenterology & Hepatology
- Non-alcoholic steatohepatitis and progression of carotid atherosclerosis in patients with type 2 diabetes: a Korean cohort study
- (2020) Hyeok-Hee Lee et al. Cardiovascular Diabetology
- Have we learnt all from Improve-It? Part I. Core results and subanalyses on the effects of ezetimibe added to statin therapy related to age, gender and selected chronic diseases (kidney disease, diabetes mellitus and non- alcoholic fatty liver disease)
- (2020) Zlatko Fras et al. Current Vascular Pharmacology
- Impact of glucagon-like peptide 1 receptor agonists and sodium-glucose transport protein 2 inhibitors on blood pressure and lipid profile
- (2020) Emir Muzurović et al. EXPERT OPINION ON PHARMACOTHERAPY
- Diabetes Mellitus and Noncardiac Atherosclerotic Vascular Disease—Pathogenesis and Pharmacological Treatment Options
- (2020) Emir M. Muzurović et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Pancreatic steatosis associates with impaired insulin secretion in genetically predisposed individuals
- (2020) Róbert Wagner et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The role of omics in the pathophysiology, diagnosis and treatment of non-alcoholic fatty liver disease
- (2020) Nikolaos Perakakis et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Commentary: From mice to men: In search for dietary interventions to form the background on which pharmacotherapy for non-alcoholic fatty liver disease should be based
- (2020) Emir Muzurović et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Non-alcoholic fatty liver disease and steatohepatitis: State of the art on effective therapeutics based on the gold standard method for diagnosis
- (2020) Maryam Mahjoubin-Tehran et al. Molecular Metabolism
- Effects of Statin Use on the Development and Progression of Nonalcoholic Fatty Liver Disease
- (2020) Jung Il Lee et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Diagnostic performance of three non-invasive fibrosis scores (Hepamet, FIB-4, NAFLD fibrosis score) in NAFLD patients from a mixed Latin American population
- (2020) Rommel Zambrano-Huailla et al. Annals of Hepatology
- Prevalence, diagnosis and treatment with 3 different statins of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis in military personnel. Do genetics play a role?
- (2020) Georgios Sfikas et al. Current Vascular Pharmacology
- Editorial on Prevalence, Diagnosis and Treatment with 3 Different Statins of Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis in Military Personnel. Do Genetics Play a Role?
- (2020) Emir Muzurović et al. Current Vascular Pharmacology
- Inflammatory Markers Associated With Diabetes Mellitus – Old and New Players
- (2020) Emir Muzurović et al. CURRENT PHARMACEUTICAL DESIGN
- A meta‐analysis on the diagnostic performance of magnetic resonance imaging and transient elastography in nonalcoholic fatty liver disease
- (2020) Qing Gu et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Factors affecting weight loss variability in obesity
- (2020) Robert Dent et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Physical Activity and Low Glycemic Index Mediterranean Diet: Main and Modification Effects on NAFLD Score. Results from a Randomized Clinical Trial
- (2020) Isabella Franco et al. Nutrients
- HOMA-IR is an independent predictor of advanced liver fibrosis in nondiabetic nonalcoholic fatty liver disease
- (2019) Hideki Fujii et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Nonalcoholic Fatty Liver Disease and the Heart
- (2019) Eric P. Stahl et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
- (2019) Peter J. Eddowes et al. GASTROENTEROLOGY
- The association between pancreas steatosis and metabolic syndrome: A systematic review and meta-analysis
- (2019) Ye Bi et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Pioglitazone: The forgotten, cost-effective cardioprotective drug for type 2 diabetes
- (2019) Ralph A DeFronzo et al. Diabetes & Vascular Disease Research
- Non-alcoholic fatty liver disease treatment in patients with type 2 diabetes mellitus; new kids on the block
- (2019) Vasilios G. Athyros et al. Current Vascular Pharmacology
- The association between liver fat and systemic calcified atherosclerosis
- (2019) Bo Kyung Koo et al. JOURNAL OF VASCULAR SURGERY
- Effect of semaglutide on liver enzymes and markers of inflammation in subjects with type 2 diabetes and/or obesity
- (2019) Philip Newsome et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Effect of metformin on all-cause and cardiovascular mortality in patients with coronary artery diseases: a systematic review and an updated meta-analysis
- (2019) Yechen Han et al. Cardiovascular Diabetology
- The Global Epidemiology of NAFLD and NASH in Patients with type 2 diabetes: A Systematic Review and Meta-analysis
- (2019) Zobair M. Younossi et al. JOURNAL OF HEPATOLOGY
- Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2019) Mansoor Husain et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nonalcoholic fatty liver disease and mortality from all causes, cardiovascular disease, and cancer: a meta-analysis
- (2019) Yan Liu et al. Scientific Reports
- Chronic kidney disease in patients with non-alcoholic fatty liver disease: What the Hepatologist should know?
- (2019) Stefania Kiapidou et al. Annals of Hepatology
- Association of epicardial adipose tissue with non-alcoholic fatty liver disease: a meta-analysis
- (2019) Bin Liu et al. Hepatology International
- Metabolic syndrome, but not non‐alcoholic fatty liver disease, increases 10‐year mortality: A prospective, community‐cohort study
- (2019) Madunil A. Niriella et al. LIVER INTERNATIONAL
- The interplay between abdominal aortic aneurysm, metabolic syndrome and fatty liver disease: a retrospective case-control study
- (2019) Mahmud Mahamid et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Non-alcoholic fatty liver disease and cardiovascular disease: assessing the evidence for causality
- (2019) Martijn C. G. J. Brouwers et al. DIABETOLOGIA
- Factors influencing subclinical atherosclerosis in patients with biopsy-proven nonalcoholic fatty liver disease
- (2019) Taeang Arai et al. PLoS One
- Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults
- (2019) Myriam Alexander et al. BMJ-British Medical Journal
- Impact of NAFLD on the Incidence of Cardiovascular Diseases in a Primary Care Population in Germany
- (2019) Christian Labenz et al. DIGESTIVE DISEASES AND SCIENCES
- Predictive models with the use of omics and supervised machine learning to diagnose non-alcoholic fatty liver disease: A “non-invasive alternative” to liver biopsy?
- (2019) Niki Katsiki et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Non-invasive diagnosis of non-alcoholic steatohepatitis and fibrosis with the use of omics and supervised learning: A proof of concept study
- (2019) Nikolaos Perakakis et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- NAFLD and Atherosclerosis: Two Sides of the Same Dysmetabolic Coin?
- (2019) Daniela Stols-Gonçalves et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Magnetic Resonance vs Transient Elastography Analysis of Patients With Non-alcoholic Fatty Liver Disease: a Systematic Review and Pooled Analysis of Individual Participants
- (2018) Cynthia Hsu et al. Clinical Gastroenterology and Hepatology
- Noninvasive Tests Do Not Accurately Differentiate Nonalcoholic Steatohepatitis From Simple Steatosis: A Systematic Review and Meta-analysis
- (2018) Pauline Verhaegh et al. Clinical Gastroenterology and Hepatology
- Is Nonalcoholic Fatty Liver Disease Indeed the Hepatic Manifestation of Metabolic Syndrome?
- (2018) Niki Katsiki et al. Current Vascular Pharmacology
- Non-alcoholic fatty liver disease is associated with stroke severity and progression of brainstem infarctions
- (2018) H. Li et al. EUROPEAN JOURNAL OF NEUROLOGY
- Imaging of nonalcoholic fatty liver disease and its clinical utility
- (2018) Evangelos Chartampilas Hormones-International Journal of Endocrinology and Metabolism
- The nonalcoholic fatty liver disease (NAFLD) fibrosis score, cardiovascular risk stratification and a strategy for secondary prevention with ezetimibe
- (2018) Tracey G. Simon et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women
- (2018) Lesley Hoyles et al. NATURE MEDICINE
- Genetic deficiency of indoleamine 2,3-dioxygenase promotes gut microbiota-mediated metabolic health
- (2018) Ludivine Laurans et al. NATURE MEDICINE
- Non-alcoholic fatty liver disease, liver biomarkers and stroke risk: The Reasons for Geographic and Racial Differences in Stroke cohort
- (2018) Kristine S. Alexander et al. PLoS One
- Non-invasive prediction of NAFLD severity: a comprehensive, independent validation of previously postulated serum microRNA biomarkers
- (2018) Mireia López-Riera et al. Scientific Reports
- Liraglutide protects non-alcoholic fatty liver disease via inhibiting NLRP3 inflammasome activation in a mouse model induced by high-fat diet
- (2018) Wei Zhu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Non-alcoholic fatty liver disease and colorectal cancer: A marker of risk or common causation?
- (2018) Niki Katsiki et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Effects of Pioglitazone on Nonalcoholic Fatty Liver Disease in the Absence of Constitutive Androstane Receptor Expression
- (2018) Hwa Young Ahn et al. PPAR Research
- Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies
- (2018) Norbert Stefan et al. Lancet Diabetes & Endocrinology
- Performance of the SteatoTest, ActiTest, NashTest and FibroTest in a multiethnic cohort of patients with type 2 diabetes mellitus
- (2018) Fernando Bril et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Metabolically healthy versus metabolically unhealthy obesity
- (2018) Carla Iacobini et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Bariatric surgery improves nonalcoholic fatty liver disease: a contemporary systematic review and meta-analysis
- (2018) Tannous K. Fakhry et al. Surgery for Obesity and Related Diseases
- Is HOMA-IR a potential screening test for non-alcoholic fatty liver disease in adults with type 2 diabetes?
- (2017) Gala Gutierrez-Buey et al. European Journal of Internal Medicine
- Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis
- (2017) Parambir S. Dulai et al. HEPATOLOGY
- Association between non-alcoholic fatty liver disease and peripheral artery disease in patients with type 2 diabetes
- (2017) Yaowu Zou et al. INTERNAL MEDICINE JOURNAL
- Non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus: Effects of statins and antidiabetic drugs
- (2017) Niki Katsiki et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- A vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease
- (2017) Zhonge Chen et al. Lipids in Health and Disease
- Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus
- (2017) Wenjie Dai et al. MEDICINE
- Effects of lifestyle interventions on clinical characteristics of patients with non-alcoholic fatty liver disease: A meta-analysis
- (2017) Christina N Katsagoni et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement
- (2017) Vasilios G. Athyros et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
- (2017) Zobair Younossi et al. Nature Reviews Gastroenterology & Hepatology
- Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes
- (2017) Philip R. Schauer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Increased risk of cerebrovascular accident related to non-alcoholic fatty liver disease: a meta-analysis
- (2017) Jianping Hu et al. Oncotarget
- Pioglitazone and cardiovascular outcomes in patients with insulin resistance, pre-diabetes and type 2 diabetes: a systematic review and meta-analysis
- (2017) Hung-Wei Liao et al. BMJ Open
- Semaglutide, lipid-lowering drugs, and NAFLD
- (2017) Niki Katsiki et al. Lancet Diabetes & Endocrinology
- Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus
- (2016) Kenneth Cusi et al. ANNALS OF INTERNAL MEDICINE
- Abnormal Peri-Organ or Intra-organ Fat (APIFat) Deposition: An Underestimated Predictor of Vascular Risk?
- (2016) Niki Katsiki et al. Current Vascular Pharmacology
- Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease
- (2016) Jérôme Boursier et al. JOURNAL OF HEPATOLOGY
- Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
- (2016) Giovanni Targher et al. JOURNAL OF HEPATOLOGY
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
- (2016) Matthew James Armstrong et al. LANCET
- Thiazolidinediones for nonalcoholic steatohepatitis
- (2016) Lingling He et al. MEDICINE
- Epidemiology and natural history of non-alcoholic fatty liver disease
- (2016) Yousef Fazel et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease
- (2016) Obesity Facts
- Pioglitazone seems safe and effective for patients with fatty liver disease and diabetes
- (2016) Jacqui Wise BMJ-British Medical Journal
- Pioglitazone seems safe and effective for patients with fatty liver disease and diabetes
- (2016) Jacqui Wise BMJ-British Medical Journal
- Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: A systematic review and meta-analysis
- (2016) Shunquan Wu et al. Scientific Reports
- Nonalcoholic fatty pancreas disease and Nonalcoholic fatty liver disease: more than ectopic fat
- (2015) C. Della Corte et al. CLINICAL ENDOCRINOLOGY
- Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
- (2015) Eduardo Vilar-Gomez et al. GASTROENTEROLOGY
- Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
- (2015) Paul Angulo et al. GASTROENTEROLOGY
- Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009
- (2015) Zobair M. Younossi et al. HEPATOLOGY
- Statin use and non-alcoholic steatohepatitis in at risk individuals
- (2015) Paola Dongiovanni et al. JOURNAL OF HEPATOLOGY
- Validation of the Fatty Liver Index for Nonalcoholic Fatty Liver Disease in Middle-Aged and Elderly Chinese
- (2015) Xiaolin Huang et al. MEDICINE
- The Genetics of Nonalcoholic Fatty Liver Disease: Spotlight on PNPLA3 and TM6SF2
- (2015) Christopher Day et al. SEMINARS IN LIVER DISEASE
- Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: An open question
- (2015) Letiția Adela Maria Streba WORLD JOURNAL OF GASTROENTEROLOGY
- Resolution of non-alcoholic steatohepatitis by rosuvastatin monotherapy in patients with metabolic syndrome
- (2015) Konstantinos Kargiotis WORLD JOURNAL OF GASTROENTEROLOGY
- Metformin and Inflammation: Its Potential Beyond Glucose-lowering Effect
- (2015) Yoshifumi Saisho Endocrine Metabolic & Immune Disorders-Drug Targets
- Should we expand the concept of coronary heart disease equivalents?
- (2014) Niki Katsiki et al. CURRENT OPINION IN CARDIOLOGY
- Association Between Nonalcoholic Fatty Liver Disease and Coronary Artery Disease Complexity in Patients With Acute Coronary Syndrome
- (2013) Mustafa Tarık Ağaç et al. ANGIOLOGY
- A systematic review: Burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; Should we care?
- (2013) Ebenezer T. Oni et al. ATHEROSCLEROSIS
- Nonalcoholic fatty liver disease and serum lipoproteins: The Multi-Ethnic Study of Atherosclerosis
- (2013) Andrew Paul DeFilippis et al. ATHEROSCLEROSIS
- Cardiovascular and Systemic Risk in Nonalcoholic Fatty Liver Disease - Atherosclerosis as a Major Player in the Natural Course of NAFLD
- (2013) Amedeo Lonardo et al. CURRENT PHARMACEUTICAL DESIGN
- Are simple noninvasive scoring systems for fibrosis reliable in patients with NAFLD and normal ALT levels?
- (2013) Stuart McPherson et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials
- (2013) Mazen Noureddin et al. HEPATOLOGY
- Effect of intensive lipid lowering with atorvastatin on cardiovascular outcomes in coronary heart disease patients with mild-to-moderate baseline elevations in alanine aminotransferase levels
- (2013) Matti J. Tikkanen et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- The Enhanced Liver Fibrosis (ELF) score: Normal values, influence factors and proposed cut-off values
- (2013) Ralf Lichtinghagen et al. JOURNAL OF HEPATOLOGY
- Redefining metabolic syndrome as a fat storage condition based on studies of comparative physiology
- (2013) Richard J. Johnson et al. Obesity
- Pathophysiology of Human Visceral Obesity: An Update
- (2013) André Tchernof et al. PHYSIOLOGICAL REVIEWS
- Independent Association between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: A Systematic Review and Meta-Analysis
- (2013) Hongyun Lu et al. International Journal of Endocrinology
- Nonalcoholic Fatty Liver Disease Is Associated With Atherosclerosis in Middle-Aged and Elderly Chinese
- (2012) Yun Huang et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Independent Association Between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease in the US Population
- (2012) Maria Stepanova et al. Clinical Gastroenterology and Hepatology
- Fatty Liver, Insulin Resistance, and Features of Metabolic Syndrome: Relationships with coronary artery calcium in 10,153 people
- (2012) K.-C. Sung et al. DIABETES CARE
- Bariatric Surgery versus Conventional Medical Therapy for Type 2 Diabetes
- (2012) Geltrude Mingrone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Decreased Circulating Endothelial Progenitor Cell Levels and Function in Patients with Nonalcoholic Fatty Liver Disease
- (2012) Chia-Hung Chiang et al. PLoS One
- The Effectiveness of Liraglutide in Nonalcoholic Fatty Liver Disease Patients with Type 2 Diabetes Mellitus Compared to Sitagliptin and Pioglitazone
- (2012) Takamasa Ohki et al. TheScientificWorldJOURNAL
- Hepatic Steatosis, Obesity, and the Metabolic Syndrome Are Independently and Additively Associated With Increased Systemic Inflammation
- (2011) Chiadi E. Ndumele et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Liver Enzymes: Potential Cardiovascular Risk Markers?
- (2011) Eirini Lioudaki et al. CURRENT PHARMACEUTICAL DESIGN
- Hyperuricaemia and Non-Alcoholic Fatty Liver Disease (NAFLD): A Relationship with Implications for Vascular Risk?
- (2011) Niki Katsiki et al. Current Vascular Pharmacology
- Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease
- (2011) V. W.-S. Wong et al. GUT
- Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: A meta-analysis
- (2011) Ruben Hernaez et al. HEPATOLOGY
- The Concept of Metabolic Syndrome: Contribution of Visceral Fat Accumulation and Its Molecular Mechanism
- (2011) Yuji Matsuzawa et al. Journal of Atherosclerosis and Thrombosis
- The association between non-alcoholic hepatic steatosis and mean platelet volume in an obese Korean population
- (2011) Woul-Young Shin et al. PLATELETS
- Relationship between white blood cell count and nonalcoholic fatty liver disease
- (2010) Yong-Jae Lee et al. DIGESTIVE AND LIVER DISEASE
- Nonalcoholic Fatty Liver Disease and Acute Ischemic Stroke
- (2010) Ivan Ying et al. EPIDEMIOLOGY
- Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: A narrative review and clinical perspective of prospective data
- (2010) Nazim Ghouri et al. HEPATOLOGY
- High-dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis: a double-blind, randomized, placebo-controlled trial
- (2010) Ulrich F. H. Leuschner et al. HEPATOLOGY
- Non-invasive assessment of hepatic steatosis: Prospective comparison of the accuracy of imaging examinations
- (2010) Seung Soo Lee et al. JOURNAL OF HEPATOLOGY
- Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis
- (2010) Vasilios G Athyros et al. LANCET
- Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
- (2010) Giovanni Targher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Assessment of Hepatic Steatosis in Patients Undergoing Liver Resection: Comparison of US, CT, T1-weighted Dual-Echo MR Imaging, and Point-resolved1H MR Spectroscopy
- (2010) Jochem R. van Werven et al. RADIOLOGY
- Harmonizing the Metabolic Syndrome
- (2009) K.G.M.M. Alberti et al. CIRCULATION
- Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
- (2009) Amy G. Shah et al. Clinical Gastroenterology and Hepatology
- Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease
- (2009) Jeong-Hoon Lee et al. DIGESTIVE AND LIVER DISEASE
- Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: A multicenter validation study
- (2009) Ariel E. Feldstein et al. HEPATOLOGY
- Evidence for the Importance of Adiponectin in the Cardioprotective Effects of Pioglitazone
- (2009) Ping Li et al. HYPERTENSION
- Metformin in patients with non-alcoholic fatty liver disease: A randomized, controlled trial
- (2009) John Willy Haukeland et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- The effect of metformin and standard therapy versus standard therapy alone in nondiabetic patients with insulin resistance and nonalcoholic steatohepatitis (NASH): a pilot trial
- (2009) William W. Shields et al. Therapeutic Advances in Gastroenterology
- Effect of Bariatric Surgery on Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis
- (2008) Rajasekhara R. Mummadi et al. Clinical Gastroenterology and Hepatology
- Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?
- (2008) G. Targher et al. DIABETOLOGIA
- Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease
- (2008) S A Harrison et al. GUT
- Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: A systematic review
- (2008) Silvia Sookoian et al. JOURNAL OF HEPATOLOGY
- 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
- (2008) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started